Tag: On-Demand Digital Pathology System

Mass Validation Study of OptraSCAN Digital Pathology Leads to Approval by Government of India

| February 7, 2018 | 0 Comments

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN today announced it has successfully completed the mass validation of its whole slide digital scanner OptraSCAN® with the support of India’s Biotechnology Industry Research […]

Continue Reading

NantOmics Launches Augmented Intelligence Program for On-Demand Digital Pathology With OptraSCAN, A Cancer MoonShot 2020 Milestone

| October 18, 2016 | 0 Comments

NantOmics and NantWork’s Machine Vision and Supercomputing Platform to be Combined with OptraSCAN to Provide Next Generation Morphological Visualization of the Tumor Microenvironment and Drive Immunotherapy Clinical Decisions and QUILT clinical trials Investment supports delivery of solutions that have potential to improve patient outcomes and precision medicine initiatives CULVER CITY, Calif. — NantOmics, LLC, the leader in […]

Continue Reading